一种基于政策的方法来优化多发性骨髓瘤治疗测序实践
Zsuzsa Réka Pozsár1,2,3, Solène Clavreul4, Lise-Lott Eriksson4
1Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
Expert review of hematology
|February 18, 2026
概括
多发性骨髓瘤治疗序列是复杂的. 当前的做法可能不会产生最佳的结果,强调需要基于证据的策略和多利益相关方的合作,以改善患者护理.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
背景情况:
- 多发性骨髓瘤 (MM) 现在是一个可管理的慢性疾病,由于治疗的进步.
- 在MM中,治疗顺序变得复杂,新的疗法往往被保留给后期阶段.
- 有限的证据支持目前保留新疗法用于高级MM阶段的现行做法.
研究的目的:
- 综合了关于MM治疗顺序的多方利益相关者讨论中的见解.
- 确定当前测序实践的驱动因素,并探索基于证据的优化策略.
- 在不断变化的MM治疗环境中解决治疗序列的复杂性.
主要方法:
- 一场涉及患者,临床医生,HTA专家和行业代表的多方利益相关者讨论.
- 综合有关当前测序实践及其潜在驱动因素的见解.
- 探索优化治疗顺序的潜在选择.
主要成果:
- 确定的主要驱动因素包括临床开发限制,指南限制,HTA挑战,财务压力和疾病负担.
- 优化选项包括新的证据生成,整体疾病建模,患者参与和扩展的评估框架.
- 不确定性显著影响MM序列决策,需要更好的证据.
结论:
- 目前的MM治疗测序实践需要重新评估,以确保最佳的长期结果.
- 解决不确定性和改善证据生成对于知情测序至关重要.
- 国际合作对于应对MM治疗序列的复杂性至关重要.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.5K
相关概念视频
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K